Filing Flows › Prime Medicine (PRME) › Q3 2025 › vs Q2 2025
Prime Medicine (PRME) Q3 2025 vs Q2 2025 (quarter over quarter)
Prime Medicine's revenue rose $110K (+10%) from $1.1M in Q2 2025 to $1.2M in Q3 2025.
Prime Medicine, Q3 2025: revenue $1.2M (+486% year over year), net loss $50.6M, operating cash flow −$35.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q3 2025 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.2M | $1.1M | $110K | +10% |
| Other income, net | $3.4M | $786K | $2.6M | +331% |
| Net loss | $50.6M | $52.6M | −$2.0M | -4% |
| Costs & expenses | $55.2M | $54.5M | $706K | +1% |
| Operating costs | $55.2M | $54.5M | $706K | +1% |
| Research & development | $44.0M | $41.4M | $2.6M | +6% |
| General & admin | $11.2M | $13.1M | −$1.9M | -15% |
| Operating cash sources | $50.6M | $52.6M | −$2.0M | -4% |
| Depreciation & amortization | $1.9M | $1.9M | $17K | +0.9% |
| Share-based compensation | $12.7M | $6.3M | $6.4M | +102% |
| Working capital & other | $915K | $3.0M | −$2.1M | -69% |
| Cash used in operations | $35.0M | $41.4M | −$6.4M | -15% |
| Net loss absorbed | $50.6M | $52.6M | −$2.0M | -4% |
Questions
How much did Prime Medicine's revenue grow quarter over quarter in Q3 2025?
Prime Medicine's revenue rose $110K (+10%) from $1.1M in Q2 2025 to $1.2M in Q3 2025.